Imagen Technologies

Medical imaging software

Imagen Technologies logo
101-200 employees
  • Healthcare
  • B2B
  • Artificial Intelligence
  • SaaS
Central Harlem, New York, NY

Company mission

To power the future of primary care with AI diagnostics, world-class specialists, and comprehensive cloud data infrastructure.

Top investors

38% employee growth in 12 months

Our take

Today, more than two-thirds of the global population lacks acccess to basic radiology services. In regions where medical staff are scarce, artifical intelligence offers a powerful tool to bridge that gap. Imagen is harnessing this potential with its technology designed to cut radiology error rates and speed up x-ray analysis. And long term, the company hopes to dsignificantly reduce radiology costs, for better are globally.

Imagen Technologies takes its place in a competitive global artificial intelligence diagnostics market, which is expected to reach a value of $1.7B by 2033.

The company's OsteoDetect software made history as the first FDA-approved tool to analyze wrist x-rays using AI. In February 2021, it raised $51M in Series C funding - bringing total investment to $35M since 2015. With this backing, the company is expanding both its product lineup and its team.

Kirsty headshot

Kirsty

Company Specialist at Welcome to the Jungle

Benefits

  • PPO: $0 deductible
  • Dental/Vision: 75% employee-only and 50% dependent coverage
  • Medical: 100% employee-only and 70% dependent coverage
  • Flex Spending Account
  • 401K Plan
  • Partners: Access to our clinical partners, some of the best in the country
  • Insurance: Employer-paid Life and Long-Term Disability insurance
  • Commuter Pre-tax Benefits

Funding (last 2 of 4 rounds)

Feb 2021

$51m

SERIES C

Sep 2018

$40m

SERIES B

Total funding: $110.3m

This company has top investors

Leadership

Robert Lindsey

(Co-Founder & CTO)

PhD from University of Colorado in Computer Science. Deep Learning Consultant and Research scientist at Boulder Analytics and Sensory Inc. respectively.

Alexander Dresner

(Co-Founder & CEO)

Investment Manager for Bridgewater Associates and Value Analyst at the Hospital of Special Surgery.